Project Grant R01AI173261
Award Date
8/19/24
Completion Date
7/31/29
Dollars Obligated
$580K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Nutley, NJ 07110, USA
Similar Awards
This Project Grant award, totaling $233,600.00 and spanning September 1, 2024 to June 30, 2027, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD), a debilitating condition characterized by chronic inflammation and erosion of intestinal functions. The...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $553,342 to the Regents of the University of Minnesota to conduct research on CD4+ T cell response to food antigens. The research aims to understand how exposure to food peptides bound to major histocompatibility complex class II (MHCII) molecules leads to the formation of regulatory T (Treg) cells and a...
This $261,492 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the impact of DNA methylation on the physiology of Clostridioides difficile, a major nosocomial pathogen. The research aims to identify specific methylation sites that regulate C. difficile sporulation, which enhances the bacterium's ability to persist. This effort builds on prior work...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides approximately $2.4 million over 3 years to the Benaroya Research Institute at Virginia Mason to investigate how genetic variants impact the function of pathogenic T cells in inflammatory bowel diseases (IBDs). The key research activities involve: Performing massively parallel...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $533,907.00 to Rutgers, The State University to investigate the role of the epigenetic regulator TET3 in protecting intestinal epithelial cells against inflammatory stressors. The project aims to decipher the mechanisms by which TET3-mediated DNA oxidation and transcriptional...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) for $516,648 supports research to investigate whether intestinal stem cells (ISCs) maintain an "inflammatory memory" following exposure to helminth infection, and how this impacts their regenerative capacity. The funded project, led by investigators at the University of California, San Francisco (UCSF), aims to...
The General Hospital Corporation (MGH) was awarded a $822,642 Project Grant from the National Institutes of Health (NIH) on September 1, 2023 under the Trans-NIH Research Support program (CFDA 93.310). The grant will fund a prospective cohort study to identify microbiome, metabolomic, and immune profiles associated with the development of celiac disease autoimmunity in high-risk infants. Specific objectives include maintaining the existing birth cohort infrastructure, investigating the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $781,685 to The Children's Hospital of Philadelphia Research Institute over 5 years starting December 2024. The funding supports research to understand the molecular circuits controlling human T follicular regulatory (Tfr) cell development and how Tfr cell defects contribute to autoimmune and immunodeficiency...
This Project Grant award of $820,623, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the genetic determinants of SPI1 expression and activity in human germinal center B cells. The research aims to: Identify non-coding regulatory elements controlling SPI1 gene expression in human germinal center B cells. Delineate the effects of SPI1 coding variants on...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $146,922 to the University of Pittsburgh to conduct research on the role of gut protist-derived compounds in modulating dietary antigen-presenting dendritic cells in celiac disease. The key objectives are to gain insights into how the gut protist Tritrichomonas arnold promotes oral tolerance and protects against...